AVANIR PHARMACEUTICALS

​Central Nervous System Pharmaceutical Research and Development/Pharmaceutical Sales

Filings
25
Clients
1
Total Income
Years Active
2014–2022

Filings

Year Client Period Income Expenses Doc
2014 AVANIR PHARMACEUTICALS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
2014 AVANIR PHARMACEUTICALS 4th Quarter (Oct 1 - Dec 31)
Registration

Clients Represented

ClientFilingsTotal Income
AVANIR PHARMACEUTICALS 25

Lobbyists

NameDisclosed Prior Position
SARAH CHRISTINE D'ORSIE Director of Advocacy
CATHERINE DRATZ FERGUSON
CRYSTAL LYNN VANUCH Head of Government Affairs